Protecting Our Essential Medicines Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill requires the Secretary of Health and Human Services to compile and maintain a confidential list of critical drugs imported into the United States, including information about their country of origin and manufacturing facilities. The bill establishes an interagency task force to identify drugs critical to public health or national security, and creates additional lists identifying drugs produced exclusively in foreign entities of concern and the top three countries from which the U.S. imports critical drugs. The lists are not publicly disclosed except for aggregate country-of-origin data, and information is shared only with national security agencies and within HHS for supply chain vulnerability assessment.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.